Girancitug
Product Specifications
CAS Number
3024821-77-7
Target
VEGFR
Related Pathways
Tyrosine Kinase/Adaptors, Angiogenesis
Bioactivity
Girancitug is a humanized IgG1κ monoclonal antibody inhibitor that targets VEGFR2/KDR/CD309. It effectively suppresses angiogenesis and is applicable in anti-angiogenic therapy research for cancers such as colorectal and ovarian cancer.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
I2269 96 Tests
Vesicle transport through interaction with t-SNAREs homolog 1B (VTI1B) Human ELISA Kit
Sign In for Pricing
View Details FAB62981S-100UG 100 µg
Human MUC-1 Alexa Fluor 750 MAb (Clone 2336A)
Sign In for Pricing
View Details 
MBS2048920-01 0.1 mL
Cy3-Linked Polyclonal Antibody to Phospholipase A2, Lipoprotein Associated (LpPLA2)
Sign In for Pricing
View Details